The first COVID-19 vaccine manufacturing plant on the African continent has opened in South Africa. While vaccination programs around the world have delivered more than ten-billion doses, sub-Saharan Africa is facing a massive shortage. In the long term, hopes are that Cape Town-based Afrigen Biologics will be able to increase local production, delivering an affordable product and reducing dependency on imports.
Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch
#Afrigen #SouthAfrica #Covid-19
Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch
#Afrigen #SouthAfrica #Covid-19
- Category
- Europe
- Tags
- DW News, afrigen, south africa
Sign in or sign up to post comments.
Be the first to comment